Clear Channel one of the UKs leading and most innovative media companies developed a world-first use of contactless technology for Cancer Research, allowing the British public the opportunity to donate £2 to Cancer Research by tapping their contactless debit or credit card on shop windows. An interactive screen was installed at each site and reacted to donations by showing people the positive impact they are making in the fight against cancer.
Onwave were contacted by Clear Channel late in the project to address connectivity issues that were being experienced in the field at certain sites
Onwave technology, was installed at Cancer Research stores in Brighton and Guildford within 24 hours providing a secure connection for the publics donations, and will be active 24-hours a day. An interactive screen will also be installed, and will react to donations by showing people the positive impact they are making in the fight against cancer.
Onwave designed, delivered and installed the mobile bonding technology, as an key element of the Clear Channel solution at Cancer Research stores in Brighton and Guildford, serviced were on line within 24 hours of Onwave being asked to assist.
We were able to provide a secure and reliable connection over secure APNs on the mobile networks to allow the public donations to be taken by Cancer Research. The project was short in duration and was active for a 1 month duration 24-hours a day.
Onwave’s agility and can do approach meant that we were able to quickly react and deliver service, designing, configuring and installing service within 24 hours.
The existing network interconnects meant that Onwave could select and deliver service using any combination of the mobile networks within a secure and bonded VPN.
“We are excited to be premiering this world-first use of contactless giving technology in four of our shop windows. The contactless giving through four of our shop windows is a new and exciting way for people to donate to our work and help us bring forward the day when all cancers are cured.”
Paul Clarke, Head of Strategic Marketing Communications at Cancer Research UK